Mobile

A prospective randomised phase III study of androgen deprivation therapy with or without local radiotherapy with or without abiraterone acetate and prednisone in patient with metastatic hormone-naïve...

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-000142-35

A prospective randomised phase III study of androgen deprivation therapy with or without local radiotherapy with or without abiraterone acetate and prednisone in patient with metastatic hormone-naïve prostate cancer

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the efficacy of androgen deprivation therapy with or without local radiotherapy with or without abiraterone acetate and prednisone in terms of overall survival (OS) and progression-free survival (PFS) in patient with metastatic hormone-naïve prostate cancer.

Critère d'inclusion

  • metastatic hormone-naïve prostate cancer

Liens